The document discusses the Federal Trade Commission's (FTC) increasing enforcement actions against intellectual property (IP) rights. Specifically, the FTC has taken action against patent settlements in the pharmaceutical industry, standard-setting abuses, and non-practicing entities. The FTC views many patents as "bad" and litigation as out of hand. There is a risk that expanded FTC enforcement could discourage participation in standard-setting organizations or patent settlements and widen the policy gap with the Department of Justice on IP issues. It is unclear if a new presidential administration would rein in the FTC's IP campaign.